Medical Developments International Limited (MVP.AX)
AUD 0.4
(-2.47%)
AUD 0.4
(-2.47%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -29.44 Million AUD | -587.35% |
| 2023 | -4.28 Million AUD | -34.59% |
| 2022 | -12.86 Million AUD | -755.7% |
| 2021 | -11.1 Million AUD | -133.33% |
| 2020 | 3.03 Million AUD | 2.48% |
| 2019 | 3.88 Million AUD | 52.25% |
| 2018 | 2.22 Million AUD | -28.11% |
| 2017 | 3.8 Million AUD | 1.04% |
| 2016 | 3.42 Million AUD | 23.02% |
| 2015 | 2.63 Million AUD | 62.82% |
| 2014 | 959 Thousand AUD | -50.89% |
| 2013 | 4 Million AUD | 16.68% |
| 2012 | 3.43 Million AUD | 52.71% |
| 2011 | 2.25 Million AUD | 38.38% |
| 2010 | 1.62 Million AUD | 5.24% |
| 2009 | 1.54 Million AUD | -4.92% |
| 2008 | 1.62 Million AUD | -20.77% |
| 2007 | 2.05 Million AUD | 30.47% |
| 2006 | 1.57 Million AUD | 39.12% |
| 2005 | 1.13 Million AUD | -0.7% |
| 2004 | 1.13 Million AUD | -79.21% |
| 2003 | 5.47 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -2 Million AUD | 0.0% |
| 2024 FY | - AUD | 21.49% |
| 2024 Q2 | -11.47 Million AUD | 0.0% |
| 2023 Q2 | -6.56 Million AUD | 0.0% |
| 2023 FY | - AUD | -34.59% |
| 2023 Q4 | -10.59 Million AUD | 0.0% |
| 2022 Q2 | -6.05 Million AUD | 0.0% |
| 2022 FY | - AUD | -755.7% |
| 2022 Q4 | -4.92 Million AUD | 0.0% |
| 2021 FY | - AUD | -133.33% |
| 2021 Q4 | -6.02 Million AUD | 0.0% |
| 2021 Q2 | 4.53 Million AUD | 0.0% |
| 2020 FY | - AUD | 2.48% |
| 2020 Q4 | 2.27 Million AUD | 0.0% |
| 2020 Q2 | 2.19 Million AUD | 0.0% |
| 2019 Q2 | 2.51 Million AUD | 0.0% |
| 2019 FY | - AUD | 52.25% |
| 2019 Q4 | 3.69 Million AUD | 0.0% |
| 2018 Q2 | 1.94 Million AUD | 0.0% |
| 2018 FY | - AUD | -28.11% |
| 2018 Q4 | 922 Thousand AUD | 0.0% |
| 2017 FY | - AUD | 1.04% |
| 2017 Q4 | 1.89 Million AUD | 0.0% |
| 2017 Q2 | 2.09 Million AUD | 0.0% |
| 2016 Q4 | 2.54 Million AUD | 0.0% |
| 2016 FY | - AUD | 23.02% |
| 2016 Q2 | 1.39 Million AUD | 0.0% |
| 2015 Q4 | 1.6 Million AUD | 0.0% |
| 2015 Q2 | 1.6 Million AUD | 0.0% |
| 2015 FY | - AUD | 62.82% |
| 2014 Q2 | 709 Thousand AUD | 0.0% |
| 2014 Q4 | 1.26 Million AUD | 0.0% |
| 2014 FY | - AUD | -50.89% |
| 2013 Q2 | 2.34 Million AUD | 0.0% |
| 2013 FY | - AUD | 16.68% |
| 2013 Q4 | 1.66 Million AUD | 0.0% |
| 2012 Q3 | 947.25 Thousand AUD | 0.0% |
| 2012 Q1 | 623.75 Thousand AUD | 0.0% |
| 2012 Q4 | 947.25 Thousand AUD | 0.0% |
| 2012 FY | - AUD | 52.71% |
| 2012 Q2 | 947.25 Thousand AUD | 51.86% |
| 2011 Q4 | 623.75 Thousand AUD | 0.0% |
| 2011 FY | - AUD | 38.38% |
| 2011 Q2 | 623.75 Thousand AUD | 95.84% |
| 2011 Q3 | 623.75 Thousand AUD | 0.0% |
| 2011 Q1 | 318.5 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 5.24% |
| 2010 Q1 | 297 Thousand AUD | 0.0% |
| 2010 Q2 | 318.5 Thousand AUD | 7.24% |
| 2010 Q3 | 318.5 Thousand AUD | 0.0% |
| 2010 Q4 | 318.5 Thousand AUD | 0.0% |
| 2009 Q1 | 326.75 Thousand AUD | 0.0% |
| 2009 Q4 | 297 Thousand AUD | 0.0% |
| 2009 Q2 | 297 Thousand AUD | -9.1% |
| 2009 Q3 | 297 Thousand AUD | 0.0% |
| 2009 FY | - AUD | -4.92% |
| 2008 Q3 | 326.75 Thousand AUD | 0.0% |
| 2008 Q4 | 326.75 Thousand AUD | 0.0% |
| 2008 Q2 | 326.75 Thousand AUD | -27.51% |
| 2008 Q1 | 450.75 Thousand AUD | 0.0% |
| 2008 FY | - AUD | -20.77% |
| 2007 Q1 | 332 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 30.47% |
| 2007 Q4 | 450.75 Thousand AUD | 0.0% |
| 2007 Q3 | 450.75 Thousand AUD | 0.0% |
| 2007 Q2 | 450.75 Thousand AUD | 35.77% |
| 2006 Q2 | 332 Thousand AUD | 89.17% |
| 2006 Q1 | 175.5 Thousand AUD | 0.0% |
| 2006 Q3 | 332 Thousand AUD | 0.0% |
| 2006 Q4 | 332 Thousand AUD | 0.0% |
| 2006 FY | - AUD | 39.12% |
| 2005 Q4 | 175.5 Thousand AUD | 0.0% |
| 2005 Q3 | 175.5 Thousand AUD | 0.0% |
| 2005 FY | - AUD | -0.7% |
| 2005 Q2 | 175.5 Thousand AUD | -45.71% |
| 2005 Q1 | 323.25 Thousand AUD | 0.0% |
| 2004 Q1 | 1.36 Million AUD | 0.0% |
| 2004 FY | - AUD | -79.21% |
| 2004 Q2 | 323.25 Thousand AUD | -76.38% |
| 2004 Q3 | 323.25 Thousand AUD | 0.0% |
| 2004 Q4 | 323.25 Thousand AUD | 0.0% |
| 2003 Q2 | 1.36 Million AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q3 | 1.36 Million AUD | 0.0% |
| 2003 Q4 | 1.36 Million AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Althea Group Holdings Limited | -28.56 Million AUD | -3.099% |
| Cann Group Limited | -35.53 Million AUD | 17.138% |
| ECS Botanics Holdings Ltd | 3.22 Million AUD | 1012.123% |
| Ecofibre Limited | -38.34 Million AUD | 23.206% |
| Elixinol Wellness Limited | -6.8 Million AUD | -332.648% |
| Hygrovest Limited | -1.1 Million AUD | -2569.628% |
| IDT Australia Limited | -5.13 Million AUD | -473.661% |
| Invion Limited | -4.57 Million AUD | -544.086% |
| Little Green Pharma Ltd | -4.64 Million AUD | -534.159% |
| Live Verdure Ltd | -12.51 Million AUD | -135.352% |
| Vitura Health Limited | 7.07 Million AUD | 516.124% |
| Vita Life Sciences Limited | 13.09 Million AUD | 324.813% |